DE2538582A1 - Secoprostaglandine - Google Patents

Secoprostaglandine

Info

Publication number
DE2538582A1
DE2538582A1 DE19752538582 DE2538582A DE2538582A1 DE 2538582 A1 DE2538582 A1 DE 2538582A1 DE 19752538582 DE19752538582 DE 19752538582 DE 2538582 A DE2538582 A DE 2538582A DE 2538582 A1 DE2538582 A1 DE 2538582A1
Authority
DE
Germany
Prior art keywords
group
general formula
acid
given above
hydroxy
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
DE19752538582
Other languages
German (de)
English (en)
Inventor
John Beeh Bicking
Jun Edward Jethro Cragoe
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Merck and Co Inc
Original Assignee
Merck and Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck and Co Inc filed Critical Merck and Co Inc
Publication of DE2538582A1 publication Critical patent/DE2538582A1/de
Withdrawn legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D303/00—Compounds containing three-membered rings having one oxygen atom as the only ring hetero atom
    • C07D303/02—Compounds containing oxirane rings
    • C07D303/38—Compounds containing oxirane rings with hydrocarbon radicals, substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D303/40—Compounds containing oxirane rings with hydrocarbon radicals, substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals by ester radicals
    • C07D303/42—Acyclic compounds having a chain of seven or more carbon atoms, e.g. epoxidised fats
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C309/00—Sulfonic acids; Halides, esters, or anhydrides thereof
    • C07C309/63—Esters of sulfonic acids
    • C07C309/64—Esters of sulfonic acids having sulfur atoms of esterified sulfo groups bound to acyclic carbon atoms
    • C07C309/65—Esters of sulfonic acids having sulfur atoms of esterified sulfo groups bound to acyclic carbon atoms of a saturated carbon skeleton
    • C07C309/66—Methanesulfonates
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C47/00—Compounds having —CHO groups
    • C07C47/20—Unsaturated compounds having —CHO groups bound to acyclic carbon atoms
    • C07C47/277—Unsaturated compounds having —CHO groups bound to acyclic carbon atoms containing ether groups, groups, groups, or groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C59/00—Compounds having carboxyl groups bound to acyclic carbon atoms and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
    • C07C59/125—Saturated compounds having only one carboxyl group and containing ether groups, groups, groups, or groups
    • C07C59/135—Saturated compounds having only one carboxyl group and containing ether groups, groups, groups, or groups containing halogen
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C59/00—Compounds having carboxyl groups bound to acyclic carbon atoms and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
    • C07C59/40—Unsaturated compounds
    • C07C59/58—Unsaturated compounds containing ether groups, groups, groups, or groups
    • C07C59/64—Unsaturated compounds containing ether groups, groups, groups, or groups containing six-membered aromatic rings
    • C07C59/66—Unsaturated compounds containing ether groups, groups, groups, or groups containing six-membered aromatic rings the non-carboxylic part of the ether containing six-membered aromatic rings
    • C07C59/68—Unsaturated compounds containing ether groups, groups, groups, or groups containing six-membered aromatic rings the non-carboxylic part of the ether containing six-membered aromatic rings the oxygen atom of the ether group being bound to a non-condensed six-membered aromatic ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C59/00—Compounds having carboxyl groups bound to acyclic carbon atoms and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
    • C07C59/40—Unsaturated compounds
    • C07C59/76—Unsaturated compounds containing keto groups
    • C07C59/90—Unsaturated compounds containing keto groups containing singly bound oxygen-containing groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D309/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings
    • C07D309/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • C07D309/08—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D309/10—Oxygen atoms
    • C07D309/12—Oxygen atoms only hydrogen atoms and one oxygen atom directly attached to ring carbon atoms, e.g. tetrahydropyranyl ethers

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Furan Compounds (AREA)
  • Pyridine Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
DE19752538582 1974-08-30 1975-08-29 Secoprostaglandine Withdrawn DE2538582A1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US50212674A 1974-08-30 1974-08-30

Publications (1)

Publication Number Publication Date
DE2538582A1 true DE2538582A1 (de) 1976-03-11

Family

ID=23996457

Family Applications (1)

Application Number Title Priority Date Filing Date
DE19752538582 Withdrawn DE2538582A1 (de) 1974-08-30 1975-08-29 Secoprostaglandine

Country Status (8)

Country Link
JP (1) JPS51125021A (sv)
CH (1) CH613683A5 (sv)
DE (1) DE2538582A1 (sv)
DK (1) DK366475A (sv)
FR (1) FR2282868A1 (sv)
GB (1) GB1478281A (sv)
NL (1) NL7509770A (sv)
SE (1) SE7509107L (sv)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4018804A (en) * 1976-04-14 1977-04-19 The Upjohn Company Intermediate for synthesis of Thromboxane B2
RU2526203C1 (ru) * 2013-02-12 2014-08-20 Федеральное государственное бюджетное образовательное учреждение высшего профессионального образования "Казанская государственная академия ветеринарной медицины им. Н.Э. Баумана" Метод получения антилютеальной крови - алк, способ лечения и профилактики послеродовых акушерско-гинекологических заболеваний у коров

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4150235A (en) * 1976-12-17 1979-04-17 Merck & Co., Inc. Interphenylene 11,12-secoprostaglandins
UA59384C2 (uk) 1996-12-20 2003-09-15 Пфайзер, Інк. Похідні сульфонамідів та амідів як агоністи простагландину, фармацевтична композиція та способи лікування на їх основі
UA67754C2 (uk) 1997-10-10 2004-07-15 Пфайзер, Інк. Агоністи простагландину, фармацевтична композиція на їх основі (варіанти), спосіб нарощення та збереження кісткової маси у хребетних та спосіб лікування (варіанти)
UA72293C2 (en) 1999-12-22 2005-02-15 Pfizer Prod Inc Ep4 receptor selective agonists (variants) for treating conditions presenting with low bone mass and pharmaceutical composition
ATE327751T1 (de) 2000-01-31 2006-06-15 Pfizer Prod Inc Verwendung von aktivatoren des prostaglandinrezeptores 4 zur behandlung von akuter oder chronischer niereninsuffizienz

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4018804A (en) * 1976-04-14 1977-04-19 The Upjohn Company Intermediate for synthesis of Thromboxane B2
RU2526203C1 (ru) * 2013-02-12 2014-08-20 Федеральное государственное бюджетное образовательное учреждение высшего профессионального образования "Казанская государственная академия ветеринарной медицины им. Н.Э. Баумана" Метод получения антилютеальной крови - алк, способ лечения и профилактики послеродовых акушерско-гинекологических заболеваний у коров

Also Published As

Publication number Publication date
GB1478281A (en) 1977-06-29
SE7509107L (sv) 1976-03-01
FR2282868B1 (sv) 1980-03-28
JPS51125021A (en) 1976-11-01
FR2282868A1 (fr) 1976-03-26
NL7509770A (nl) 1976-03-02
DK366475A (da) 1976-03-01
CH613683A5 (en) 1979-10-15

Similar Documents

Publication Publication Date Title
EP0232779B1 (de) Vinylphenolderivate, ihre Herstellung und Verwendung
DE3219244A1 (de) Sulfonatderivate, verfahren zu ihrer herstellung und diese derivate enthaltende arzneimittel
US3991106A (en) 16-Ethers of 8-aza-9-dioxothia-11,12-seco-prostaglandins
DE2342118C2 (de) Phenoxypropionsäurederivate, Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende pharmazeutische Zubereitungen
EP0058370A1 (de) Tetrahydronaphthalin- und Indanverbindungen, ihre Herstellung und pharmazeutische Präparate
DE2538582A1 (de) Secoprostaglandine
DE2814321A1 (de) Interphenylen-8-aza-9-dioxothia- 11,12-secoprostaglandine
DE1593036A1 (de) Substituierte p-Cyclohexyl-phenyl-essigsaeuren,Derivate derselben und ein Verfahren zur Herstellung dieser Verbindungen
US4055596A (en) 11,12-Seco-prostaglandins
US4020177A (en) Substituted phenoxy-tridecanoic acids
DE2637098A1 (de) Phenoxyalkylcarbonsaeurederivate und verfahren zu ihrer herstellung
AT395421B (de) Verfahren zur herstellung von neuen cyclopenthylethern
US4126629A (en) Substituted phenoxy-tridecenoic acids/esters
DE2755759A1 (de) 4-(4-acyl-3-hydroxy-8-methyltridecyl)- benzoesaeuren
DE3102769A1 (de) "bis-moranolinderivate"
DE2315355A1 (de) Verfahren zur herstellung von oximen
DE3202065A1 (de) Substituierte n-(tetrazol-5-yl)-benzoesaeureamide, ihre herstellung und diese enthaltende pharmazeutische zubereitungen
DE3125059A1 (de) Dioxybenzoletherderivate, diese enthaltende arzneimittel, verfahren zu ihrer herstellung und ihre verwendung
DE2458911A1 (de) 11,12-secoprostaglandine und verfahren zu ihrer herstellung
DE1618643A1 (de) Aryloxysubstituierte Carbonsaeuren und Verfahren zu deren Herstellung
DE2528070A1 (de) 9-thia-, 9-oxothia- und 9-dioxothia- 11,12-secoprostaglandine
DE2524394A1 (de) Alpha-aminomethyl-3-aethyl-4-hydroxybenzylalkoholderivate, verfahren zu ihrer herstellung und arzneimittel
DE2331081A1 (de) Neue cyclopentanderivate und verfahren zu ihrer herstellung
DE3321662A1 (de) Polyenverbindungen
DE2354085C3 (de) 11,12 -Secoprostaglandine, Arzneimittel, welche diese enthalten, und Verfahren zu ihrer Herstellung

Legal Events

Date Code Title Description
8139 Disposal/non-payment of the annual fee